Humana Inc. (0J6Z.L)
USD 266.03
(-6.17%)
USD 266.03
(-6.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 47.06 Billion USD | 7.64% |
| 2022 | 43.72 Billion USD | -2.29% |
| 2021 | 44.74 Billion USD | 27.57% |
| 2020 | 35.07 Billion USD | 20.78% |
| 2019 | 29.04 Billion USD | 14.6% |
| 2018 | 25.34 Billion USD | -5.02% |
| 2017 | 26.68 Billion USD | 6.78% |
| 2016 | 24.99 Billion USD | 1.26% |
| 2015 | 24.67 Billion USD | 4.89% |
| 2014 | 23.52 Billion USD | 13.47% |
| 2013 | 20.73 Billion USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 50.09 Billion USD | 0.0% |
| 2024 Q3 | 50 Billion USD | -0.17% |
| 2024 Q1 | 50.09 Billion USD | 6.82% |
| 2023 Q4 | 46.89 Billion USD | -16.12% |
| 2023 Q3 | 55.9 Billion USD | -0.97% |
| 2023 Q2 | 56.45 Billion USD | 3.07% |
| 2023 FY | 46.89 Billion USD | 7.24% |
| 2023 Q1 | 54.77 Billion USD | 25.27% |
| 2022 Q4 | 43.72 Billion USD | -13.87% |
| 2022 Q2 | 46.82 Billion USD | 1.11% |
| 2022 Q1 | 46.3 Billion USD | 3.49% |
| 2022 FY | 43.72 Billion USD | -2.29% |
| 2022 Q3 | 50.76 Billion USD | 8.43% |
| 2021 Q2 | 38.07 Billion USD | 1.75% |
| 2021 FY | 44.74 Billion USD | 27.57% |
| 2021 Q4 | 44.74 Billion USD | -1.26% |
| 2021 Q3 | 45.32 Billion USD | 19.04% |
| 2021 Q1 | 37.41 Billion USD | 6.99% |
| 2020 Q1 | 34.63 Billion USD | 19.12% |
| 2020 Q3 | 38.47 Billion USD | 0.06% |
| 2020 FY | 35.07 Billion USD | 20.78% |
| 2020 Q4 | 34.96 Billion USD | -9.12% |
| 2020 Q2 | 38.45 Billion USD | 11.04% |
| 2019 Q4 | 29.07 Billion USD | -0.36% |
| 2019 FY | 29.04 Billion USD | 14.6% |
| 2019 Q3 | 29.18 Billion USD | 0.92% |
| 2019 Q2 | 28.91 Billion USD | 1.99% |
| 2019 Q1 | 28.34 Billion USD | 11.55% |
| 2018 Q2 | 34.27 Billion USD | 2.44% |
| 2018 Q1 | 33.45 Billion USD | 23.09% |
| 2018 FY | 25.34 Billion USD | -5.02% |
| 2018 Q3 | 27.49 Billion USD | -19.78% |
| 2018 Q4 | 25.41 Billion USD | -7.56% |
| 2017 Q2 | 32.25 Billion USD | 1.71% |
| 2017 Q3 | 32.95 Billion USD | 2.18% |
| 2017 FY | 26.68 Billion USD | 6.78% |
| 2017 Q4 | 27.17 Billion USD | -17.53% |
| 2017 Q1 | 31.71 Billion USD | 24.87% |
| 2016 Q4 | 25.39 Billion USD | -13.81% |
| 2016 Q2 | 27.23 Billion USD | 1.12% |
| 2016 Q1 | 26.93 Billion USD | 9.14% |
| 2016 Q3 | 29.46 Billion USD | 8.19% |
| 2016 FY | 24.99 Billion USD | 1.26% |
| 2015 Q2 | 25.38 Billion USD | -0.94% |
| 2015 FY | 24.67 Billion USD | 4.89% |
| 2015 Q4 | 24.67 Billion USD | 1.57% |
| 2015 Q3 | 24.29 Billion USD | -4.29% |
| 2015 Q1 | 25.62 Billion USD | 8.91% |
| 2014 Q2 | 23.12 Billion USD | 2.46% |
| 2014 Q3 | 24.33 Billion USD | 5.23% |
| 2014 Q4 | 23.52 Billion USD | -3.3% |
| 2014 Q1 | 22.56 Billion USD | 8.83% |
| 2014 FY | 23.52 Billion USD | 13.47% |
| 2013 FY | 20.73 Billion USD | 0.0% |
| 2013 Q1 | 20.97 Billion USD | 0.0% |
| 2013 Q2 | 20.84 Billion USD | -0.6% |
| 2013 Q3 | 20.9 Billion USD | 0.26% |
| 2013 Q4 | 20.73 Billion USD | -0.8% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -12583.078% |
| Accuray Incorporated | 468.62 Million USD | -9943.169% |
| Align Technology, Inc. | 6.08 Billion USD | -673.602% |
| Elevance Health Inc. | 108.92 Billion USD | 56.793% |
| AxoGen, Inc. | 196.82 Million USD | -23811.862% |
| Boston Scientific Corporation | 35.13 Billion USD | -33.951% |
| CVS Health Corporation | 249.72 Billion USD | 81.153% |
| Cardinal Health, Inc. | 45.12 Billion USD | -4.308% |
| Centene Corporation | 84.64 Billion USD | 44.395% |
| DaVita Inc. | 17.61 Billion USD | -167.119% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 16.271% |
| Hologic, Inc. | 9.15 Billion USD | -414.035% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -1343.745% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -181.403% |
| Masimo Corporation | 3.04 Billion USD | -1447.427% |
| McKesson Corporation | 67.44 Billion USD | 30.215% |
| Patterson Companies, Inc. | 2.96 Billion USD | -1485.181% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -235.651% |
| ResMed Inc. | 6.87 Billion USD | -584.841% |
| Henry Schein, Inc. | 10.57 Billion USD | -345.143% |
| Teladoc Health, Inc. | 4.39 Billion USD | -971.517% |
| Universal Health Services, Inc. | 14.35 Billion USD | -227.823% |
| Veeva Systems Inc. | 5.91 Billion USD | -696.238% |
| Baxter International Inc. | 28.27 Billion USD | -66.449% |
| Becton, Dickinson and Company | 52.78 Billion USD | 10.828% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -204.796% |
| Danaher Corporation | 84.48 Billion USD | 44.294% |
| Stryker Corporation | 39.91 Billion USD | -17.922% |
| Medtronic plc | 89.98 Billion USD | 47.695% |